News
RIS News Read more from R&IS News
Press Releases Read more from Press Releases
Gold medallist joins charity netball tournament at the University of Warwick raising over £32,000
National cancer support charity Look Good Feel Better teamed up with England Netball to host its Annual Charity Netball Tournament at the University of Warwick, raising over £32,000 for people undergoing treatment for cancer.
International Day of Women and Girls in Science: Physicist advancing skin cancer screening and diagnosis using terahertz waves
Ahead of International Day of Women and Girls in Science this Sunday, 11 February, The University of Warwick is shining the spotlight on a physicist who is developing new technology to advance the diagnosis and screening of skin cancers.
AI tool developed to help grade cancer based on cell divisions
Ahead of World Cancer Day on 4 February, scientists are revealing a cutting-edge artificial intelligence (AI) tool designed to help grade cancer, by analysing cell division.
Digital pathology cleared for use in cancer screening programmes
New research funded by the National Institute for Health and Care Research (NIHR) has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples.
AI research at the University of Warwick will speed up colon cancer diagnoses, thanks to a £2.6m grant
Artificial Intelligence (AI) will help to speed up colon cancer diagnoses, thanks to a £2.6m research grant.
Cancer origin identified through cell ‘surgery’ – new research
Research from the University of Warwick sheds new light on a key cause of cancer formation during cell division (or mitosis), and points towards potential solutions for preventing it from occurring.
New deep learning algorithm can pick up genetic mutations and DNA mismatch repair deficiency in colorectal cancers more efficiently
A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.
Scientists able to see how potential cancer treatment reacts in single cell
Using a 185 metre beamline at the Diamond synchrotron, researchers could see how Osmium, a rare precious metal that could be used for cancer treatments, reacts in a single human lung cancer cell. This is a major step forward in discovering new anti-cancer drugs for researchers at the University of Warwick.
Child brain tumours can be classified by advanced imaging and AI
Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of Warwick has found. This means that the tumour can be characterised and treated more efficiently.
Artificial intelligence helps predict risk of developing mouth cancer
Artificial intelligence can help doctors better predict the risk of patients developing oral cancer, new research from the University of Sheffield and University of Warwick has revealed.
Light-activated metal catalyst destroys cancer cells’ vital energy source
A space-age metal that formed part of the asteroid that destroyed the dinosaurs could provide a new method of treating cancer tumours selectively using light.
AI can predict the chances of surviving oral cancer
· State-of-the-art AI algorithms applied to digitised images of oral cancer tissue specimens can be used to predict chances of survival by measuring the abundance of Tumour infiltrating immune cells, a study led by University of Warwick shows.
Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return
A new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast cancer patients does not increase the risk of their cancer returning.
Novel anti-cancer drug delivery system being presented in Parliament by Warwick student
Sean Ellacott, 25, a third year PhD student at the University of Warwick, , is attending Parliament to present his chemistry research about the interaction of self-assembling nanotubes with biological models, which are currently being considered for the delivery of anticancer drugs, to a range of politicians and a panel of expert judges, as part of STEM for BRITAIN on Wednesday 13 March.
Simply shining light on dinosaur metal compound kills cancer cells
A new compound based on Iridium, a rare metal which landed in the Gulf of Mexico 66 M years ago, hooked onto albumin, a protein in blood, can attack the nucleus of cancerous cells when switched on by light, University of Warwick researchers have found.
Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds
A new study funded by Cancer Research UK and sponsored by the University of Warwick has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.
Warwick awarded £2.3 million to help develop cutting-edge technologies for cancer diagnosis and personalised treatment
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest £10 million in the PathLAKE project as part of the Industrial Strategy Challenge Fund. The University of Warwick has been awarded £2.3 million of the funding which will be used to create innovative solutions in digital pathology and Artificial Intelligence (AI) to speed up the time in which cancer is diagnosed and treated.
Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
Study that finds women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.
Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism
Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.
Light-activated cancer drugs without toxic side effects: fresh insight
Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia).